The largest database of trusted experimental protocols

212 gd cf

Manufactured by R&D Systems

The 212-GD/CF is a laboratory equipment product designed for research and development purposes. Its core function is to perform cell culture-related tasks, but a detailed description of its intended use cannot be provided in an unbiased and factual manner while maintaining conciseness.

Automatically generated - may contain errors

5 protocols using 212 gd cf

1

Glutamatergic Neuron Differentiation from ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neuronal differentiation of ESCs into cortical glutamatergic neurons was carried out as previously described92 (link). In brief, the differentiation was carried out by adding doxycycline hyclate (2 μg/mL) to N2 supplemented media (Thermo Fisher, 17502048) with patterning factors SB431542 (Tocris, 1614, 10 μM), XAV939 (Stemgent, 04–00046, 2 μM) and LDN-193189 (Stemgent, 04–0074, 100 nM), as described previously92 (link)–94 (link). Puromycin selection was used (5μg/μL), from days 2 to 6 to remove non-transduced cells. At 4 days post induction, neuronal cells were resuspended into Neurobasal media (Gibco, 21103049) that was supplemented with B27 (Gibco, 17504044, 50X), doxycycline (2 μg/mL), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), and glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257–33 NT/CF, and 212-GD/CF at 10 ng/mL each). From this point onwards the neurons were either co-cultured with murine glial cells that were derived from early postnatal (P1-P3) mouse brains as described previously95 (link) or were left to grow as monocultures (mouse strain https://www.jax.org/strain/100012; animal ethical committee approval by Harvard University: Animal Experimentation Protocol (AEP) # 93–15).
+ Open protocol
+ Expand
2

Differentiation of hPSCs into Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
hPSCs were co-infected with TetO-Ngn2-Puro and TetO-GFP (gift from the Wernig Lab) and reverse tetracycline-controlled transactivator (rtTA), and were plated at a density of 100,000 cells/cm2 with rock inhibitor Y27632 (Stemgent 04-0012). Day 1 cells were differentiated in KSR media with 10 μM SB431542 (1614, Tocris), 2 μM XAV939 (04-00046, Stemgent) and 100 nM LDN-193189 (04-0074, Stemgent) along with doxycycline hyclate (2 μg/mL) (maintained for the entire differentiation process, unless noted). Day 2 media were 50% KSR+SB/XAV/LDN and 50% N2 supplemented with puromycin (5 μg/μL), and differentiation media were as previously described (Maroof et al., 2013 (link)). Day 3, N2 media, day 4, neurobasal media (Gibco) supplemented with B27 (50×, Gibco), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), and glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257-NT/CF, and 212-GD/CF at 10 ng/mL). When co-cultured with glia, day 4 cells were dissociated with accutase and plated at a density of 40,000/cm2 with mouse primary cortical glial cells (seeded at 70,000/cm2 glia) on geltrex-coated plates. Primary glial preparations from post-natal day (P)0–P2 mouse pups were obtained as previously described (Di Giorgio et al., 2008 (link)).
+ Open protocol
+ Expand
3

Differentiation of hPSCs into Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
hPSCs were co-infected with TetO-Ngn2-Puro and TetO-GFP (gift from the Wernig Lab) and reverse tetracycline-controlled transactivator (rtTA), and were plated at a density of 100,000 cells/cm2 with rock inhibitor Y27632 (Stemgent 04-0012). Day 1 cells were differentiated in KSR media with 10 μM SB431542 (1614, Tocris), 2 μM XAV939 (04-00046, Stemgent) and 100 nM LDN-193189 (04-0074, Stemgent) along with doxycycline hyclate (2 μg/mL) (maintained for the entire differentiation process, unless noted). Day 2 media were 50% KSR+SB/XAV/LDN and 50% N2 supplemented with puromycin (5 μg/μL), and differentiation media were as previously described (Maroof et al., 2013 (link)). Day 3, N2 media, day 4, neurobasal media (Gibco) supplemented with B27 (50×, Gibco), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), and glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257-NT/CF, and 212-GD/CF at 10 ng/mL). When co-cultured with glia, day 4 cells were dissociated with accutase and plated at a density of 40,000/cm2 with mouse primary cortical glial cells (seeded at 70,000/cm2 glia) on geltrex-coated plates. Primary glial preparations from post-natal day (P)0–P2 mouse pups were obtained as previously described (Di Giorgio et al., 2008 (link)).
+ Open protocol
+ Expand
4

Generation of Neuronal Cell Villages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell villages were generated as described previously.27 (link),28 (link) At day 3 of the differentiation, the differentiating cells from 48 donors were passaged into differentiation media that was supplemented with 5-Ethynyl-2’-deoxyuridine (Life Technologies, A10044, 10 μM). Cell villages of the immature neurons were generated at day 6 by dissociating the cells with Accutase®, counting them by the Scepter Automated Cell Counter (Millipore Sigma) and plating the cells at a density of 40 000 cells/cm2 in Neurobasal media (Gibco, 21103049) supplemented with B27 (Gibco, 17504044, 50X), doxycycline (2 μg/mL), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), and glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257-33 NT/CF, and 212-GD/CF at 10 ng/mL each). Neuronal villages were either grown as monocultures or co-cultured with murine glial cells (at a density of 70 000 cells/cm2). Villages were harvested for single cell RNA sequencing at day 28 of the differentiation.
+ Open protocol
+ Expand
5

Differentiation of iPSCs into Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs stably expressing TetO-Ngn2-Neo and reverse tetracycline-controlled transactivator (rtTA) were plated at a density of 40,000 cells cm−2 with rock inhibitor Y27632 (Stemgent, 04-0012). Day 1 cells were differentiated in N2 media (Life Technologies) supplemented with 10 μM SB431542 (Tocris, 1614), 2 μM XAV939 (Stemgent, 04-00046) and 100 nM LDN-193189 (Stemgent, 04-0074) along with doxycycline hyclate (2 μg mL−1). Day 2 media was N2+SB/XAV/LDN/doxycycline hyclate and differentiation media were as previously described. On day 3, cell differentiation was continued in neurobasal media (Life Technologies) supplemented with B27 (50X, Thermo Scientific), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CTNF), glial cell-derived neurotrophic factor (GDNF) (R&D Systems 248-BD/CF, 257-NT/CF, and 212-GD/CF at 10 ng mL−1) and doxycyclinehyclate (2 μg mL−1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!